Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/943   
Active ingredient: Mogamulizumab
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: Kyowa Kirin Limited
Galabank Business Park, Galashiels, TD1 1QH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/01/2012 Orphan designation EMA/OD/104/11 (2012)129 of 11/01/2012
26/04/2012 Transfer of orphan designation EMA/OD/104/11/T/01 (2012)2899 of 23/04/2012
04/07/2016 Change of name and/or address of sponsor